Improvement of RBD‐FC Immunogenicity by Using Alum–Sodium Alginate Adjuvant Against SARS‐COV‐2
Influenza and Other Respiratory Viruses · 2024
DOI: 10.1111/irv.70018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Influenza and Other Respiratory Viruses, 2024. Verfasst von Mahboobeh Dehghan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cellular and Molecular Biology, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran. Hauptthemen laut MEDLINE: Alginates, Alum Compounds, Adjuvants, Immunologic, Antibodies, Viral. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Adjuvants use several mechanisms to boost immunogenicity and to modulate immune response. The strength of adsorption of antigen by adjuvants can be a determinant factor for significant improvement of immunopotentiation.
Methods
We expressed recombinant RBD‐FC in PichiaPink Strain 4 and examined the vaccination of mice by vaccine formulation with different adjuvants (sodium alginate and aluminum hydroxide, alone and together).
Results
Sodium alginate significantly increased the immunogenicity and stability of RBD‐FC antigen, so RBD‐FC formulated with combined alginate and alum (AlSa) and sodium alginate alone showed higher antibody titer and stability. Immunogenicity of RBD‐FC:AlSa was determined by serological assays including direct enzyme‐linked immunosorbent assay (ELISA) and surrogate virus neutralization test (sVNT). High levels of IgGs and neutralizing antibodies were measured in serum of mice immunized with the RBD‐FC:AlSa formulation. On the other hand, cytokines IL‐10 and INF‐γ were severely accumulated in response to RBD‐FC:AlSa, and after 10 days, their accumulation was significantly declined, whereas IL‐4 showed the highest and the lowest accumulation in response to alum and alginate, respectively.
Conclusions
Our data may suggest that combination of alum and sodium alginate has a better compatibility with RBD‐FC in vaccine formulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cellular and Molecular Biology, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran.
- Protein Research Center, Shahid Beheshti University, Tehran, Iran.
Zitieren
APA
Dehghan, M., Askari, H., Tohidfar, M., Siadat, S. O. R., & Fatemi, F. (2024). Improvement of RBD‐FC Immunogenicity by Using Alum–Sodium Alginate Adjuvant Against SARS‐COV‐2. Influenza and Other Respiratory Viruses. https://doi.org/10.1111/irv.70018
Vancouver
Dehghan M, Askari H, Tohidfar M, Siadat SOR, Fatemi F. Improvement of RBD‐FC Immunogenicity by Using Alum–Sodium Alginate Adjuvant Against SARS‐COV‐2. Influenza and Other Respiratory Viruses. 2024. doi:10.1111/irv.70018
BibTeX
@article{Dehghan2024,
author = {Dehghan, Mahboobeh and Askari, Hossein and Tohidfar, Masoud and Siadat, Seyed Omid Ranaei and Fatemi, Fataneh},
title = {Improvement of RBD‐FC Immunogenicity by Using Alum–Sodium Alginate Adjuvant Against SARS‐COV‐2},
journal = {Influenza and Other Respiratory Viruses},
year = {2024},
doi = {10.1111/irv.70018}
}
EUVIMED